1.A non-toxic recombinant protein rSUMO-CPBm4 as a potential vaccine candidate against Clostridium perfringens type C beta enterotoxemia
Gao, Y. ; Du, J.G. ; Jirapattharasate, C. ; Galon, E. ; Ji, S.W. ; Ran, Z.G. ; Xia, Y.Q.
Tropical Biomedicine 2023;40(No.4):400-405
Beta toxin (CPB) is a lethal toxin and plays a key role in enterotoxemia of ruminants caused by Clostridium
perfringens type C strain. The existing vaccines based on crude CPB need time-consuming detoxification
and difficult quality control steps. In this study, we synthesized the rCPBm4 of C. perfringens type C
strain and small ubiquitin-like modifier (SUMO)-tag CPBm4 (rSUMO-CPBm4) by introducing four amino
acid substitutions: R212E, Y266A, L268G, and W275A. Compared with rCPBm4, rSUMO-CPBm4 was
expressed with higher solubility in Escherichia coli BL21 (DE3). Neither rCPBm4 nor rSUMO-CPBm4 was
lethal to mice. Although rCPBm4 and rSUMO-CPBm4 were reactogenic with polyclonal antibodies against
crude CPB, rabbits vaccinated with rSUMO-CPBm4 developed significant levels of toxin-neutralizing
antibody (TNA) titers that conferred protection against crude toxin challenge. These data suggest that
genetically detoxified rSUMO-CPBm4 is a promising subunit vaccine candidate for C. perfringens type
C beta enterotoxemia.